Translational Development Acquisition Corp. Files 8-K
Ticker: TDACW · Form: 8-K · Filed: Dec 31, 2024 · CIK: 1926599
Sentiment: neutral
Topics: corporate-structure, filing-update, spac
Related Tickers: TDACU
TL;DR
TDACU filed an 8-K detailing its share structure and corporate info.
AI Summary
Translational Development Acquisition Corp. filed an 8-K on December 31, 2024, reporting an event that occurred on December 24, 2024. The filing details the company's structure, including Class A Ordinary Shares and Redeemable Warrants, and provides its business and mailing address in New York. The company is incorporated in the Cayman Islands.
Why It Matters
This 8-K filing provides an update on the corporate structure and reporting details for Translational Development Acquisition Corp., which is relevant for investors tracking the company's status.
Risk Assessment
Risk Level: low — This filing is primarily informational, detailing corporate structure and addresses, with no immediate financial or operational risks indicated.
Key Players & Entities
- Translational Development Acquisition Corp. (company) — Registrant
- December 24, 2024 (date) — Earliest event reported
- December 31, 2024 (date) — Filing date
- 52 E 83RD ST., NEW YORK, NY 10028 (address) — Business and mailing address
- Class A Ordinary Shares (security) — Component of the company's structure
- Redeemable Warrants (security) — Component of the company's structure
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report current information about Translational Development Acquisition Corp., including details about its corporate structure and addresses, as of December 24, 2024.
When was this 8-K filed with the SEC?
This 8-K was filed with the SEC on December 31, 2024.
Where is Translational Development Acquisition Corp. incorporated?
Translational Development Acquisition Corp. is incorporated in the Cayman Islands.
What are the key components of the company's units mentioned in the filing?
The company's units, referred to as TDACU, consist of one Class A Ordinary Share and one-half of one Redeemable Warrant.
What is the exercise price for the Redeemable Warrants?
The filing indicates that each whole warrant is exercisable for one Class A Ordinary Share at an exercise price of $11.50.
Filing Stats: 723 words · 3 min read · ~2 pages · Grade level 10.3 · Accepted 2024-12-31 17:17:30
Key Financial Figures
- $0.0001 — nsisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemab
- $11.50 — ordinary share at an exercise price of $11.50 TDACW The Nasdaq Stock Market LLC
- $10.00 — hare. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to
- $172,500,000 — rating gross proceeds to the Company of $172,500,000. Simultaneously with the closing of th
- $1.00 — PO, in each case at a purchase price of $1.00 per Private Placement Warrant, generati
- $7,075,000 — rating gross proceeds to the Company of $7,075,000. A total of $174,225,000 net proceeds
- $174,225,000 — the Company of $7,075,000. A total of $174,225,000 net proceeds from the IPO and the sale
Filing Documents
- tm2432245d1_8k.htm (8-K) — 37KB
- tm2432245d1_ex99-1.htm (EX-99.1) — 113KB
- 0001104659-24-132921.txt ( ) — 405KB
- tdacu-20241224.xsd (EX-101.SCH) — 4KB
- tdacu-20241224_def.xml (EX-101.DEF) — 27KB
- tdacu-20241224_lab.xml (EX-101.LAB) — 37KB
- tdacu-20241224_pre.xml (EX-101.PRE) — 26KB
- tm2432245d1_8k_htm.xml (XML) — 8KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. The following exhibits are being filed herewith: 99.1 Audited Balance Sheet as of December 24, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 31, 2024 TRANSLATIONAL DEVELOPMENT ACQUISITION CORP. By: /s/ Michael B. Hoffman Name: Michael B. Hoffman Title: Chief Executive Officer